Variant report
Variant | esv3337928 |
---|---|
Chromosome Location | chr8:1224995-1227218 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr8:1218051..1219861-chr8:1223791..1226453,2 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs200028216 | chr8:1225027-1225028 | Weak transcription Genic enhancers Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs534608557 | chr8:1225050-1225051 | Weak transcription Genic enhancers Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs149907534 | chr8:1225091-1225092 | Weak transcription Genic enhancers Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs546139101 | chr8:1225096-1225097 | Weak transcription Genic enhancers Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs369149371 | chr8:1225098-1225099 | Weak transcription Genic enhancers Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs572279383 | chr8:1225101-1225102 | Weak transcription Genic enhancers Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs540899107 | chr8:1225135-1225136 | Weak transcription Genic enhancers Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs561051327 | chr8:1225152-1225153 | Weak transcription Genic enhancers Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs532895029 | chr8:1225158-1225159 | Weak transcription Genic enhancers Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs529853216 | chr8:1225193-1225194 | Weak transcription Genic enhancers Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs543538281 | chr8:1225197-1225198 | Weak transcription Genic enhancers Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs543037025 | chr8:1225202-1225203 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs117028631 | chr8:1225228-1225229 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs566278742 | chr8:1225256-1225257 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs116523914 | chr8:1225289-1225290 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs541158694 | chr8:1225304-1225305 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs552115143 | chr8:1225342-1225343 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs566264989 | chr8:1225345-1225346 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs113417814 | chr8:1225361-1225362 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs201904626 | chr8:1225362-1225363 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs370324779 | chr8:1225374-1225375 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs78239917 | chr8:1225375-1225376 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs553415883 | chr8:1225380-1225381 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs143102795 | chr8:1225432-1225433 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs548680238 | chr8:1225446-1225447 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs142919016 | chr8:1225452-1225453 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs537533294 | chr8:1225473-1225474 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs568312421 | chr8:1225497-1225498 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs76661909 | chr8:1225498-1225499 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs557044047 | chr8:1225506-1225507 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs570576308 | chr8:1225556-1225557 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs539470093 | chr8:1225596-1225597 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs373146473 | chr8:1225601-1225602 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs75915801 | chr8:1225607-1225608 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs368226666 | chr8:1225652-1225653 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs73170407 | chr8:1225701-1225702 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
37 | rs574689617 | chr8:1225708-1225709 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs34634474 | chr8:1225715-1225716 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs34271225 | chr8:1225716-1225717 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs397759307 | chr8:1225728-1225729 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs543603362 | chr8:1225752-1225753 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs563388885 | chr8:1225781-1225782 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs12678613 | chr8:1225797-1225798 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs12678614 | chr8:1225818-1225819 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs12679067 | chr8:1225819-1225820 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs12678617 | chr8:1225825-1225826 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs12678618 | chr8:1225831-1225832 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs12679069 | chr8:1225837-1225838 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs12678619 | chr8:1225838-1225839 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs71190711 | chr8:1225868-1225869 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Ovarian cancer | 21720365 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Congenital diaphragmatic hernia | 21341218 | CNVD |
Cancer | 18840272 | CNVD |
Pilocytic astrocytoma | 18622384 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Prostate cancer | 16573809 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
abnormal development | 18461090 | CNVD |
Crohn''s disease | 19220326 | CNVD |
Psoriasis | 19220326 | CNVD |
Prostate cancer | 21965145 | CNVD |
Prostate cancer | 18515986 | CNVD |
Chronic obstructive pulmonary disease | 20378733 | CNVD |
Autism | 18414403 | CNVD |
Cancer | 21183584 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Breast cancer | 17603634 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Cervical cancer | 17311676 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Schizophrenia | 20877625 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Breast cancer | 17001317 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Heart disease | 21282601 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Colorectal cancer | 21297112 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Breast cancer | 17133270 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Breast cancer | 17393978 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Cancer | 21637783 | CNVD |
Breast cancer | 20837533 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 22429812 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Breast cancer | 21264507 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Oral cancer | 21386901 | CNVD |
Prostate cancer | 21088497 | CNVD |
Breast cancer | 20940404 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Gastric cancer | 17167181 | CNVD |
Prostate cancer | 16705090 | CNVD |
8p-syndrome | 17576883 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Lung adenocarcinoma | 19525976 | CNVD |
Lung cancer | 19525976 | CNVD |
Prostate cancer | 17245344 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Cancer | 16751803 | CNVD |
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Cancer | 20164919 | CNVD |
Breast cancer | 21785460 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Lung cancer | 18438408 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Ductal carcinoma | 22052326 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Breast cancer | 21509527 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Epilepsy | 22083797 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Breast cancer | 21364760 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21858162 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Autism | 22495311 | CNVD |
Autism | 20531469 | CNVD |
Breast cancer | 20932292 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Congenital diaphragmatic hernia | 21064195 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:1217400-1229600 | Weak transcription | Gastric | stomach |
2 | chr8:1223600-1225200 | Weak transcription | H9 Cell Line | embryonic stem cell |
3 | chr8:1223600-1231800 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
4 | chr8:1223800-1242200 | Weak transcription | iPS DF 6.9 Cell Line | embryonic stem cell |
5 | chr8:1224800-1225000 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
6 | chr8:1225000-1225200 | Genic enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
7 | chr8:1225000-1225200 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
8 | chr8:1225200-1225600 | Enhancers | H9 Cell Line | embryonic stem cell |
9 | chr8:1225200-1232000 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |